| Filed On | Filing |
|---|---|
| 04 Nov 2021 |
8-K/A: Completion of Acquisition or Disposition of Assets
We have audited the accompanying consolidated financial statements of BioLegend, Inc. and subsidiaries, which comprise the consolidated balance sheet as of December 31, 2020, and the related consolidated statements of income, comprehensi... |
| 28 Feb 2018 |
8-K/A: Completion of Acquisition or Disposition of Assets
We have audited the accompanying consolidated financial statements of EUROIMMUN Medizinische Labordiagnostika AG and its subsidiaries, which comprise the consolidated balance sheet as of December 31, 2016, and the related consolidated st... |
| 19 Jan 2012 |
8-K/A: Completion of Acquisition or Disposition of Assets
The Board of Directors and Stockholders of Caliper Life Sciences, Inc. |
| 24 Apr 2003 |
8-K/A: Regulation FD Disclosure
- GAAP EPS FROM CONTINUING OPERATIONS OF $.03 PER SHARE, UP FROM A LOSS OF ($.17) PER SHARE IN Q1 02 |
| 05 Dec 2002 |
8-K/A: Regulation FD Disclosure
PerkinElmer, Inc., a Massachusetts corporation, is filing this current report on Form 8-K for the purpose of filing with the Securities and Exchange Commission presentation materials relating to its planned private placement of senior su... |
| 10 Dec 2001 |
8-K/A: Financial Statements and Exhibits
As independent public accountants, we hereby consent to the inclusion in this Form 8-K/A of our report dated February 8, 2001 (except for the second paragraph of Note 1 and all of Note 15 as to which the date is February 28, 2001, Note 1... |
| 11 Aug 1999 |
8-K/A: Financial Statements and Exhibits
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| 30 Mar 1999 |
8-K/A: Financial Statements and Exhibits
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| 10 Mar 1999 |
8-K/A: Financial Statements and Exhibits
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| 26 Feb 1999 |
8-K/A: Financial Statements and Exhibits
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| 06 Jan 1997 |
8-K/A: Other Events
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| 03 Jan 1997 |
8-K/A: Other Events
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
Loading...